These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 9526710)
1. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Nasr A; Breckwoldt M Gynecol Endocrinol; 1998 Feb; 12(1):43-59. PubMed ID: 9526710 [TBL] [Abstract][Full Text] [Related]
3. [Hormone replacement therapy and cardiovascular risk]. Maffei S; De Caterina R G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173 [TBL] [Abstract][Full Text] [Related]
4. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Lip GY; Blann AD; Jones AF; Beevers DG Am Heart J; 1997 Oct; 134(4):764-71. PubMed ID: 9351746 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by estrogens: mechanisms of action--the lipids. Samsioe G Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():43-9. PubMed ID: 8199640 [TBL] [Abstract][Full Text] [Related]
6. [Estrogen replacement therapy and cardiovascular disease in postmenopausal women. II. Mechanisms of action of estrogens]. Sitruk-Ware R Presse Med; 1990 Sep; 19(29):1364-7. PubMed ID: 2146610 [TBL] [Abstract][Full Text] [Related]
7. Noncontraceptive estrogen use and cardiovascular disease. Bush TL; Barrett-Connor E Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919 [TBL] [Abstract][Full Text] [Related]
8. Estrogens and atherosclerosis. Nathan L; Chaudhuri G Annu Rev Pharmacol Toxicol; 1997; 37():477-515. PubMed ID: 9131262 [TBL] [Abstract][Full Text] [Related]
9. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Knopp RH Obstet Gynecol; 1988 Nov; 72(5 Suppl):23S-30S. PubMed ID: 3050656 [TBL] [Abstract][Full Text] [Related]
10. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
11. The metabolic impact of oral contraceptives. Krauss RM; Burkman RT Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443 [TBL] [Abstract][Full Text] [Related]
12. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
13. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? LaRosa JC Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306 [TBL] [Abstract][Full Text] [Related]
15. [Hormone substitution in the menopause: effect on lipids and cardiovascular risk]. Keller U Schweiz Rundsch Med Prax; 1991 Apr; 80(16):413-7. PubMed ID: 2038637 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones]. Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240 [TBL] [Abstract][Full Text] [Related]
17. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. Lobo RA J Clin Endocrinol Metab; 1991 Nov; 73(5):925-30. PubMed ID: 1939531 [No Abstract] [Full Text] [Related]
18. Oestrogens and the heart. Rosano GM; Panina G Therapie; 1999; 54(3):381-5. PubMed ID: 10500455 [TBL] [Abstract][Full Text] [Related]
20. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications]. Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]